2015 Q4 Form 10-K Financial Statement

#000082787117000002 Filed on March 15, 2017

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2015 Q2
Revenue $18.18M $5.736M $6.002M
YoY Change 224.64% 104.13% 3.63%
Cost Of Revenue $2.600M $3.753M $3.348M
YoY Change 45.9% 72.55% 115.17%
Gross Profit $15.58M $1.983M $2.654M
YoY Change 308.07% 212.28% -37.35%
Gross Profit Margin 85.7% 34.57% 44.22%
Selling, General & Admin $5.610M $5.460M $5.111M
YoY Change 52.03% 41.67% 91.21%
% of Gross Profit 36.01% 275.34% 192.58%
Research & Development $8.780M $6.911M $5.878M
YoY Change 120.27% 17.37% 29.33%
% of Gross Profit 56.35% 348.51% 221.48%
Depreciation & Amortization $80.00K $10.00K $10.00K
YoY Change 515.38% -50.0% -50.0%
% of Gross Profit 0.51% 0.5% 0.38%
Operating Expenses $14.39M $16.12M $14.34M
YoY Change 18.29% 35.3% 63.4%
Operating Profit $1.193M -$10.39M -$8.335M
YoY Change -118.17% 14.07% 179.51%
Interest Expense $0.00 $5.000K $3.000K
YoY Change -100.0% 150.0% -40.0%
% of Operating Profit 0.0%
Other Income/Expense, Net $0.00 $3.000K $5.000K
YoY Change 50.0% -89.58%
Pretax Income $1.190M -$10.39M -$8.330M
YoY Change -118.13% 14.07% 183.91%
Income Tax -$30.00K -$218.0K -$153.0K
% Of Pretax Income -2.52%
Net Earnings $1.220M -$10.17M -$8.177M
YoY Change -122.16% 11.68% 178.7%
Net Earnings / Revenue 6.71% -177.25% -136.24%
Basic Earnings Per Share $0.08 -$0.65 -$0.53
Diluted Earnings Per Share $0.07 -$0.65 -$0.53
COMMON SHARES
Basic Shares Outstanding 15.59M shares 15.59M shares 15.55M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q4 2015 Q3 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $79.10M $96.00M $103.7M
YoY Change 126.65% 124.82% 108.23%
Cash & Equivalents $79.08M $71.98M $13.69M
Short-Term Investments $0.00 $24.00M $90.00M
Other Short-Term Assets $220.0K $159.0K $198.0K
YoY Change -23.88% -51.67% -51.56%
Inventory $15.04M $7.348M $2.325M
Prepaid Expenses
Receivables $26.27M $12.22M $12.98M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $122.3M $120.3M $120.6M
YoY Change 145.96% 126.89% 108.73%
LONG-TERM ASSETS
Property, Plant & Equipment $2.205M $1.803M $374.0K
YoY Change 544.74% 424.13% 4.03%
Goodwill $0.00
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $143.0K $111.0K $104.0K
YoY Change 217.78% 146.67% 131.11%
Total Long-Term Assets $2.348M $1.914M $478.0K
YoY Change 506.72% 392.03% 18.17%
TOTAL ASSETS
Total Short-Term Assets $122.3M $120.3M $120.6M
Total Long-Term Assets $2.348M $1.914M $478.0K
Total Assets $124.6M $122.2M $121.0M
YoY Change 148.74% 128.82% 108.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.857M $14.15M $4.783M
YoY Change 10.17% 248.56% 89.76%
Accrued Expenses $24.41M $14.44M $13.54M
YoY Change 100.62% 49.3% 81.26%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $34.26M $34.59M $24.58M
YoY Change 54.43% 70.25% 51.28%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $34.26M $34.59M $24.58M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $34.30M $34.60M $24.60M
YoY Change 54.5% 70.44% 51.85%
SHAREHOLDERS EQUITY
Retained Earnings -$107.1M -$108.3M -$98.16M
YoY Change -2.34% 3.99% 3.25%
Common Stock $15.00K $15.00K $15.00K
YoY Change 7.14% 7.14% 6.99%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change
Treasury Stock Shares 0.000 shares
Shareholders Equity $90.34M $87.63M $96.45M
YoY Change
Total Liabilities & Shareholders Equity $124.6M $122.2M $121.0M
YoY Change 148.74% 128.82% 108.1%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2015 Q2
OPERATING ACTIVITIES
Net Income $1.220M -$10.17M -$8.177M
YoY Change -122.16% 11.68% 178.7%
Depreciation, Depletion And Amortization $80.00K $10.00K $10.00K
YoY Change 515.38% -50.0% -50.0%
Cash From Operating Activities -$16.80M -$6.640M -$12.12M
YoY Change 113.33% -6.87% 160.09%
INVESTING ACTIVITIES
Capital Expenditures -$480.0K -$1.070M -$290.0K
YoY Change -4463.64% 10600.0% 2800.0%
Acquisitions
YoY Change
Other Investing Activities $24.00M $66.00M -$74.00M
YoY Change 20.0% -430.0%
Cash From Investing Activities $23.52M $64.93M -$74.29M
YoY Change 17.67% -424.49% 742800.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 380.0K 0.000 170.0K
YoY Change 1017.65% -100.0% -140.48%
NET CHANGE
Cash From Operating Activities -16.80M -6.640M -12.12M
Cash From Investing Activities 23.52M 64.93M -74.29M
Cash From Financing Activities 380.0K 0.000 170.0K
Net Change In Cash 7.100M 58.29M -86.24M
YoY Change -41.55% -315.25% 1594.3%
FREE CASH FLOW
Cash From Operating Activities -$16.80M -$6.640M -$12.12M
Capital Expenditures -$480.0K -$1.070M -$290.0K
Free Cash Flow -$16.32M -$5.570M -$11.83M
YoY Change 106.95% -21.77% 154.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0000827871
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15227165 shares
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016Q2 dei Entity Public Float
EntityPublicFloat
364085254 USD
CY2016 dei Entity Registrant Name
EntityRegistrantName
Eagle Pharmaceuticals, Inc.
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015Q4 egrx Accrued Product Costs Current
AccruedProductCostsCurrent
9232000 USD
CY2016Q4 egrx Accrued Product Costs Current
AccruedProductCostsCurrent
2856000 USD
CY2015Q4 egrx Accrued Researchand Development Current
AccruedResearchandDevelopmentCurrent
1784000 USD
CY2016Q4 egrx Accrued Researchand Development Current
AccruedResearchandDevelopmentCurrent
3528000 USD
CY2012Q1 egrx Asset Purchase Agreement Royalty On Net Profitsof Products Term
AssetPurchaseAgreementRoyaltyOnNetProfitsofProductsTerm
P10Y
CY2016 egrx Classof Warrantor Right Expected Term
ClassofWarrantorRightExpectedTerm
P6Y
CY2016 egrx Classof Warrantor Right Term Commencement Period After Closing Date
ClassofWarrantorRightTermCommencementPeriodAfterClosingDate
P1Y
CY2008Q2 egrx Collaborative Product Development Agreement Cumulative Milestones Upon Achievementof Goals
CollaborativeProductDevelopmentAgreementCumulativeMilestonesUponAchievementofGoals
13000000 USD
CY2008Q2 egrx Collaborative Product Development Agreement Monthly Receivable
CollaborativeProductDevelopmentAgreementMonthlyReceivable
200000 USD
CY2008Q2 egrx Collaborative Product Development Agreement Non Refundable Amount Receivedfor Signing
CollaborativeProductDevelopmentAgreementNonRefundableAmountReceivedforSigning
750000 USD
CY2008Q2 egrx Collaborative Product Development Agreement Paymentfor Product Development
CollaborativeProductDevelopmentAgreementPaymentforProductDevelopment
2000000 USD
CY2015Q4 egrx Deferred Tax Assets In Process Researchand Development Credit
DeferredTaxAssetsInProcessResearchandDevelopmentCredit
1884000 USD
CY2016Q4 egrx Deferred Tax Assets In Process Researchand Development Credit
DeferredTaxAssetsInProcessResearchandDevelopmentCredit
1643000 USD
CY2015Q4 egrx Deferred Tax Liabilities Fixed Assets
DeferredTaxLiabilitiesFixedAssets
0 USD
CY2016Q4 egrx Deferred Tax Liabilities Fixed Assets
DeferredTaxLiabilitiesFixedAssets
78000 USD
CY2014 egrx Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit
EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefit
0.00
CY2014Q4 egrx Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit
EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefit
0.00
CY2015 egrx Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit
EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefit
0.00
CY2016 egrx Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit
EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefit
0.07
CY2012Q1 egrx Expected Cash Proceeds Upon Regulatory Approval Milestone
ExpectedCashProceedsUponRegulatoryApprovalMilestone
1000000 USD
CY2014 egrx Increase Decreasein Prepaid Expenseand Other Current Assets Total
IncreaseDecreaseinPrepaidExpenseandOtherCurrentAssetsTotal
-192000 USD
CY2014Q4 egrx Increase Decreasein Prepaid Expenseand Other Current Assets Total
IncreaseDecreaseinPrepaidExpenseandOtherCurrentAssetsTotal
-71000 USD
CY2015 egrx Increase Decreasein Prepaid Expenseand Other Current Assets Total
IncreaseDecreaseinPrepaidExpenseandOtherCurrentAssetsTotal
225000 USD
CY2016 egrx Increase Decreasein Prepaid Expenseand Other Current Assets Total
IncreaseDecreaseinPrepaidExpenseandOtherCurrentAssetsTotal
9423000 USD
CY2016 egrx Marketing Rights Term
MarketingRightsTerm
P10Y
CY2012Q1 egrx Milestonereductionfor Regulatory Approvalof Generic Competitor Minimum
MilestonereductionforRegulatoryApprovalofGenericCompetitorMinimum
500000 USD
CY2014 egrx Noncash Operating Activity Deferred Rent
NoncashOperatingActivityDeferredRent
0 USD
CY2014Q4 egrx Noncash Operating Activity Deferred Rent
NoncashOperatingActivityDeferredRent
0 USD
CY2015 egrx Noncash Operating Activity Deferred Rent
NoncashOperatingActivityDeferredRent
367000 USD
CY2016 egrx Noncash Operating Activity Deferred Rent
NoncashOperatingActivityDeferredRent
0 USD
CY2016Q4 egrx Number Of Products
NumberOfProducts
5 product
CY2014 egrx Operating Loss Carryforwards Sales
OperatingLossCarryforwardsSales
25389000 USD
CY2014Q4 egrx Operating Loss Carryforwards Sales
OperatingLossCarryforwardsSales
12588000 USD
CY2014 egrx Paymentsfor Contingent Consideration
PaymentsforContingentConsideration
0 USD
CY2014Q4 egrx Paymentsfor Contingent Consideration
PaymentsforContingentConsideration
0 USD
CY2015 egrx Paymentsfor Contingent Consideration
PaymentsforContingentConsideration
0 USD
CY2016 egrx Paymentsfor Contingent Consideration
PaymentsforContingentConsideration
286000 USD
CY2015Q4 egrx Prepaid Fda User Fee
PrepaidFDAUserFee
551000 USD
CY2016Q4 egrx Prepaid Fda User Fee
PrepaidFDAUserFee
1592000 USD
CY2015Q4 egrx Prepaid Product Costs
PrepaidProductCosts
85000 USD
CY2016Q4 egrx Prepaid Product Costs
PrepaidProductCosts
7600000 USD
CY2015Q4 egrx Prepaid Research And Development
PrepaidResearchAndDevelopment
283000 USD
CY2016Q4 egrx Prepaid Research And Development
PrepaidResearchAndDevelopment
21000 USD
CY2016 egrx Product Development Agreements Exclusive Rights Acquired Numberof Products
ProductDevelopmentAgreementsExclusiveRightsAcquiredNumberofProducts
33 product
CY2016Q4 egrx Related Party Base Fee Due After Fifth Year
RelatedPartyBaseFeeDueAfterFifthYear
0 USD
CY2016Q4 egrx Related Party Base Fee Duein Fifth Year
RelatedPartyBaseFeeDueinFifthYear
0 USD
CY2016Q4 egrx Related Party Base Fee Duein Fourth Year
RelatedPartyBaseFeeDueinFourthYear
0 USD
CY2016Q4 egrx Related Party Base Fee Duein Second Year
RelatedPartyBaseFeeDueinSecondYear
0 USD
CY2016Q4 egrx Related Party Base Fee Duein Third Year
RelatedPartyBaseFeeDueinThirdYear
0 USD
CY2016Q4 egrx Related Party Base Fee Future Minimum Payments Remainderof Fiscal Year
RelatedPartyBaseFeeFutureMinimumPaymentsRemainderofFiscalYear
4530000 USD
CY2016Q4 egrx Related Party Base Fee Payable
RelatedPartyBaseFeePayable
4530000 USD
CY2016 egrx Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercised Intrinsic Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisedIntrinsicValue
11521000 USD
CY2014Q3 egrx Sharebased Compensation Arrangementby Sharebased Payment Award Options Outstanding Nonexercisable Number
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingNonexercisableNumber
712901 shares
CY2014Q4 egrx Sharebased Compensation Arrangementby Sharebased Payment Award Options Outstanding Nonexercisable Number
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingNonexercisableNumber
710486 shares
CY2015Q4 egrx Sharebased Compensation Arrangementby Sharebased Payment Award Options Outstanding Nonexercisable Number
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingNonexercisableNumber
1176140 shares
CY2016Q4 egrx Sharebased Compensation Arrangementby Sharebased Payment Award Options Outstanding Nonexercisable Number
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingNonexercisableNumber
1281208 shares
CY2014Q1 egrx Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
1788 shares
CY2014Q1 egrx Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
1788 shares
CY2014 egrx Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
21000 USD
CY2014 egrx Tax Credit Carryforwardsales
TaxCreditCarryforwardsales
177000 USD
CY2014Q4 egrx Tax Credit Carryforwardsales
TaxCreditCarryforwardsales
15000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3857000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14716000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26267000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42194000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24405000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
25237000 USD
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
792000 USD
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2094000 USD
CY2015Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2242000 USD
CY2016Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
6003000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
865000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1506000 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
197440000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
213872000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
606000 USD
CY2014Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
284000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4051000 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9768000 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
606000 USD
CY2014Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
284000 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4051000 USD
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9768000 USD
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 USD
CY2014Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 USD
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 USD
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
948000 USD
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3871141 shares
CY2014Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1302685 shares
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
96610 shares
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
869957 shares
CY2015Q4 us-gaap Assets
Assets
124605000 USD
CY2016Q4 us-gaap Assets
Assets
214320000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
122257000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
109110000 USD
CY2014 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2014Q4 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2015 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2016 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
957000 USD
CY2015Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 USD
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1012000 USD
CY2015Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0 USD
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
22129000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10456000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22722000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34869000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
79083000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52820000 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12266000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12147000 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
44214000 USD
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-26263000 USD
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2106545 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15636387 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15890862 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
15000 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
16000 USD
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5042000 USD
CY2014Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1782000 USD
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7762000 USD
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
34320000 USD
CY2013Q4 us-gaap Cost Of Revenue
CostOfRevenue
2670000 USD
CY2014Q4 us-gaap Cost Of Revenue
CostOfRevenue
1782000 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2014Q4 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1175000 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-1295000 USD
CY2014Q4 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-1059000 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3000 USD
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2094000 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-1295000 USD
CY2014Q4 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-1059000 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000 USD
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
919000 USD
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2014Q4 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-29553000 USD
CY2015Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 USD
CY2016Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
28643000 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2014Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-30120000 USD
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
88000 USD
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3109000 USD
CY2014 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0 USD
CY2014Q4 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0 USD
CY2015 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0 USD
CY2016 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-30116000 USD
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6000000 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2014Q4 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-567000 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
38606000 USD
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
31752000 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
28643000 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
30837000 USD
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
17700000 USD
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
254000 USD
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
285000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2790000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
4993000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses
741000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses
1946000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2100000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5185000 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
38518000 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
2944000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
7000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
7000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
81000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
80000 USD
CY2014 us-gaap Depreciation
Depreciation
104000 USD
CY2014Q4 us-gaap Depreciation
Depreciation
13000 USD
CY2015 us-gaap Depreciation
Depreciation
112000 USD
CY2016 us-gaap Depreciation
Depreciation
641000 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
104000 USD
CY2014Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13000 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
112000 USD
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
641000 USD
CY2014 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1666000 USD
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.97
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.38
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.75
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.24
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.44
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.97
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.31
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.52
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.96
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.07
CY2014Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.16
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.52
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2014Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.32
CY2014Q4 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.31
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.25
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.79
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.01
CY2014Q4 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.00
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.01
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.01
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.07
CY2014Q4 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.16
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.00
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.03
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.01
CY2014Q4 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.03
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.10
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.03
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
15476000 USD
CY2014 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
573000 USD
CY2013Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
191000 USD
CY2014Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
0 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
948000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
17827000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2846000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
3246000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3289000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3143000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3021000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
0 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34320000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
33372000 USD
CY2014 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2014Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2015 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2014Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2016 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1750000 USD
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-273000 USD
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2015Q4 us-gaap Goodwill
Goodwill
0 USD
CY2016Q4 us-gaap Goodwill
Goodwill
39743000 USD
CY2014 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2014Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2015 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2016 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2014 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2014Q4 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2015 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2016 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19272000 USD
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3255000 USD
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6565000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2574000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
53427000 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1295000 USD
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1059000 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-28026000 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2014Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
482000 USD
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
2800000 USD
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2867000 USD
CY2014Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-558000 USD
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
356000 USD
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10668000 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2172000 USD
CY2014Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4660000 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14311000 USD
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15919000 USD
CY2014 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6692000 USD
CY2014Q4 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2494000 USD
CY2015 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
11873000 USD
CY2016 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-316000 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3435000 USD
CY2014Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-65000 USD
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-520000 USD
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6000000 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1294000 USD
CY2014Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-52000 USD
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13800000 USD
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12303000 USD
CY2014Q4 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 USD
CY2014 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1000 USD
CY2015 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
98000 USD
CY2016 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
7000 USD
CY2014 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2014Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2015 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1003627 shares
CY2016 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
900423 shares
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 USD
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33372000 USD
CY2014 us-gaap Interest Expense
InterestExpense
8000 USD
CY2013Q4 us-gaap Interest Expense
InterestExpense
0 USD
CY2014Q4 us-gaap Interest Expense
InterestExpense
1000 USD
CY2015 us-gaap Interest Expense
InterestExpense
11000 USD
CY2016 us-gaap Interest Expense
InterestExpense
8000 USD
CY2014 us-gaap Interest Paid
InterestPaid
8000 USD
CY2014Q4 us-gaap Interest Paid
InterestPaid
1000 USD
CY2015 us-gaap Interest Paid
InterestPaid
11000 USD
CY2016 us-gaap Interest Paid
InterestPaid
8000 USD
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
311000 USD
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
708000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
15042000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
2739000 USD
CY2015Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
8687000 USD
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1131000 USD
CY2015Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
6044000 USD
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
900000 USD
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
31000 USD
CY2013Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000 USD
CY2014Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000 USD
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
25000 USD
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
84000 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
277000 USD
CY2014Q4 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
68000 USD
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
514000 USD
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
634000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
124605000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
214320000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
34262000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
40965000 USD
CY2014 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
2506000 USD
CY2014Q4 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1556000 USD
CY2015 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
4752000 USD
CY2016 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
14784000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46154000 USD
CY2014Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55813000 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-33670000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20045000 USD
CY2014Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19988000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1881000 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45800000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13843000 USD
CY2014Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7875000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9718000 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
53207000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-17977000 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-3255000 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-5506000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
2571000 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
81453000 USD
CY2013Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4387000 USD
CY2014Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5506000 USD
CY2014 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-19643000 USD
CY2014Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5506000 USD
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
19697000 USD
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8177000 USD
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-10167000 USD
CY2015Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1218000 USD
CY2015 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2571000 USD
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-896000 USD
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
13099000 USD
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
11952000 USD
CY2016Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
57298000 USD
CY2016 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
81453000 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 USD
CY2014Q4 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 USD
CY2015 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 USD
CY2016 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
22470000 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-515000 USD
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-190000 USD
CY2014Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14000 USD
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
76000 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
37856000 USD
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
8557000 USD
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
12165000 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
63667000 USD
CY2016 us-gaap Operating Expenses
OperatingExpenses
136131000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-18757000 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3065000 USD
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6565000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
20090000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
2560000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8335000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10388000 USD
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1193000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-897000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13656000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
12308000 USD
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
28284000 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
53351000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1973000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
0 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
281000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
564000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
564000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
564000 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
521000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1688000 USD
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
220000 USD
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
355000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
143000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
136000 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
35000 USD
CY2014Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2014 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
3765000 USD
CY2014Q4 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
0 USD
CY2015 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
45000000 USD
CY2016 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
49796000 USD
CY2014 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2014Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
37003000 USD
CY2014 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1000 USD
CY2014Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2015 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2016 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2014 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 USD
CY2014Q4 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 USD
CY2015 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 USD
CY2016 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
4850000 USD
CY2014 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2014Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2015 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2014Q4 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2015 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2016 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
26860000 USD
CY2014 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
14250000 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46000 USD
CY2014Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11000 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1881000 USD
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1590000 USD
CY2014 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
19999000 USD
CY2014Q4 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2015 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
105999000 USD
CY2016 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
62000000 USD
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1500000 shares
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1500000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1865000 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11357000 USD
CY2015Q4 us-gaap Prepaid Insurance
PrepaidInsurance
218000 USD
CY2016Q4 us-gaap Prepaid Insurance
PrepaidInsurance
135000 USD
CY2015Q4 us-gaap Prepaid Taxes
PrepaidTaxes
508000 USD
CY2016Q4 us-gaap Prepaid Taxes
PrepaidTaxes
1654000 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
6500000 USD
CY2014Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
46069000 USD
CY2014 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
46069000 USD
CY2014Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
CY2015 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
CY2016 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2014Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
54331000 USD
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2014 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
0 USD
CY2014Q4 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
19999000 USD
CY2015 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
105999000 USD
CY2016 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
62000000 USD
CY2014 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2014Q4 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2015 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2016 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1750000 USD
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
65000 USD
CY2014Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
34000 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1482000 USD
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3619000 USD
CY2016 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3070000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4822000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2205000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3316000 USD
CY2014Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
21000 USD
CY2014Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
21000 USD
CY2014 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
21000 USD
CY2014Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2016Q4 us-gaap Purchase Obligation
PurchaseObligation
16512000 USD
CY2016Q4 us-gaap Purchase Obligation Due After Fifth Year
PurchaseObligationDueAfterFifthYear
0 USD
CY2016Q4 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
0 USD
CY2016Q4 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
0 USD
CY2016Q4 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
0 USD
CY2016Q4 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
0 USD
CY2016Q4 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
16512000 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16816000 USD
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2589000 USD
CY2014Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3986000 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27855000 USD
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30262000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-107112000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25659000 USD
CY2014 us-gaap Royalty Expense
RoyaltyExpense
6672000 USD
CY2013Q4 us-gaap Royalty Expense
RoyaltyExpense
1954000 USD
CY2014Q4 us-gaap Royalty Expense
RoyaltyExpense
2707000 USD
CY2015 us-gaap Royalty Expense
RoyaltyExpense
7885000 USD
CY2016 us-gaap Royalty Expense
RoyaltyExpense
20986000 USD
CY2014 us-gaap Royalty Revenue
RoyaltyRevenue
10708000 USD
CY2013Q4 us-gaap Royalty Revenue
RoyaltyRevenue
3268000 USD
CY2014Q4 us-gaap Royalty Revenue
RoyaltyRevenue
4094000 USD
CY2015 us-gaap Royalty Revenue
RoyaltyRevenue
8259000 USD
CY2016 us-gaap Royalty Revenue
RoyaltyRevenue
99040000 USD
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4626000 USD
CY2013Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2224000 USD
CY2014Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1506000 USD
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
12968000 USD
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
40646000 USD
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
19099000 USD
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
5492000 USD
CY2014Q4 us-gaap Sales Revenue Net
SalesRevenueNet
5600000 USD
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
36309000 USD
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
6002000 USD
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
5736000 USD
CY2014Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3690000 USD
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20165000 USD
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
37833000 USD
CY2016Q4 us-gaap Sales Revenue Net
SalesRevenueNet
81140000 USD
CY2016 us-gaap Sales Revenue Net
SalesRevenueNet
189482000 USD
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9326000 USD
CY2013Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1344000 USD
CY2015Q4 us-gaap Sales Revenue Net
SalesRevenueNet
18180000 USD
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
66227000 USD
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
29591000 USD
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
40918000 USD
CY2016 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
3046000 USD
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
46048000 USD
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
52313000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
606000 USD
CY2014Q4 us-gaap Share Based Compensation
ShareBasedCompensation
284000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
4051000 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
9768000 USD
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.3364
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.3945
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.2840
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.3095
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.6400
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.3290
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.3236
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0216
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0216
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0209
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0234
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0177
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0211
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0142
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0094
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
11310 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
39596 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
98230 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
29000 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
773458 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
792500 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.61
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.73
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.92
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
27.79
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5900000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
9600000 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
54700000 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
59200000 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1308993 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1322170 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1844842 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2324918 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.16
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.29
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.16
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.06
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
16.94
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.53
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
596092 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
611684 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
668702 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1043710 shares
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y
CY2016 us-gaap Stock Issued1
StockIssued1
3046000 USD
CY2014Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4513 shares
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
211190 shares
CY2014Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.62
CY2014Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.61
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
48.65
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
81.61
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
214194 shares
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
54331000 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
65000 USD
CY2014Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
34000 USD
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1482000 USD
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3619000 USD
CY2016Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
-87929000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
33096000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
27908000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
90343000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
151226000 USD
CY2014 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
1666000 USD
CY2013Q4 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
1132000 USD
CY2014Q4 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0 USD
CY2015 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0 USD
CY2016 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0 USD
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
566838 shares
CY2016Q4 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
276244 shares
CY2016 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
566838 shares
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
0 USD
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
37003000 USD
CY2016Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
19000000 USD
CY2016 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
37000000 USD
CY2016 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
37003000 USD
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9955937 shares
CY2014Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14032828 shares
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16253781 shares
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16434104 shares
CY2013Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3048131 shares
CY2014Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14032828 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9955937 shares
CY2014Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14032828 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15250154 shares
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15533681 shares
CY2016 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior year amounts to conform with the current year presentation</font></div></div>
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These financial statements are presented in U.S. dollars and are prepared in accordance with U.S. GAAP. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed financial statements including disclosure of contingent assets and contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period and accompanying notes. The Company's critical accounting policies are those that are both most important to the Company's financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the financial statements, actual results may materially vary from these estimates.</font></div></div>

Files In Submission

Name View Source Status
0000827871-17-000002-index-headers.html Edgar Link pending
0000827871-17-000002-index.html Edgar Link pending
0000827871-17-000002.txt Edgar Link pending
0000827871-17-000002-xbrl.zip Edgar Link pending
copyofegrx_10kx2016.htm Edgar Link pending
copyofegrx_xchart-38817.jpg Edgar Link pending
copyofexhibit102610k2016.htm Edgar Link pending
copyofexhibit102710k2016.htm Edgar Link pending
copyofexhibit10710k2016.htm Edgar Link pending
copyofexhibit21110k2016.htm Edgar Link pending
copyofexhibit23110k2016.htm Edgar Link pending
copyofexhibit31110k2016.htm Edgar Link pending
copyofexhibit31210k2016.htm Edgar Link pending
copyofexhibit32110k2016.htm Edgar Link pending
egrx-20161231.xml Edgar Link completed
egrx-20161231.xsd Edgar Link pending
egrx-20161231_cal.xml Edgar Link unprocessable
egrx-20161231_def.xml Edgar Link unprocessable
egrx-20161231_lab.xml Edgar Link unprocessable
egrx-20161231_pre.xml Edgar Link unprocessable
ex1026final.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending